Hit to lead optimization of isopentenyl chalcones as novel MTHFD2 inhibitors for cancer treatment: design, synthesis, in-vitro, in-vivo and in-silico studies

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (82173857, 82373913, 82373739)
  • Shanghai Municipal Education Commission
  • National Key Research and Development Program of China (2023YFA1802000)

This publication has 34 references indexed in Scilit: